新冠肺炎的发现蛋白质组学：我们现在所处的位置。
Discovery Proteomics for COVID-19: Where We Are Now.
机构信息
Advanced Clinical Biosystems Institute and the Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
出版信息
J Proteome Res. 2021 Oct 1;20(10):4627-4639. doi: 10.1021/acs.jproteome.1c00475. Epub 2021 Sep 22.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible coronavirus responsible for the pandemic coronavirus disease 2019 (COVID-19), which has had a devastating impact on society. Here, we summarize proteomic research that has helped elucidate hallmark proteins associated with the disease with respect to both short- and long-term diagnosis and prognosis. Additionally, we review the highly variable humoral response associated with COVID-19 and the increased risk of autoimmunity.
摘要
严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）是一种高传染性的冠状病毒，可引起大流行的 2019 年冠状病毒病（COVID-19），对社会造成了毁灭性影响。在这里，我们总结了有助于阐明与短期和长期诊断和预后相关的疾病特征蛋白的蛋白质组学研究。此外，我们还回顾了与 COVID-19 相关的高度可变的体液反应以及自身免疫风险增加的情况。
相似文献
1
Discovery Proteomics for COVID-19: Where We Are Now.新冠肺炎的发现蛋白质组学：我们现在所处的位置。
J Proteome Res. 2021 Oct 1;20(10):4627-4639. doi: 10.1021/acs.jproteome.1c00475. Epub 2021 Sep 22.
2
Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.蛋白质组学方法研究 SARS-CoV-2 生物学和 COVID-19 病理学。
J Proteome Res. 2021 Feb 5;20(2):1133-1152. doi: 10.1021/acs.jproteome.0c00764. Epub 2021 Jan 19.
3
Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications.人支气管-肺蛋白质组学在 2019 年冠状病毒病（COVID-19）大流行中的应用和意义。
Expert Rev Proteomics. 2021 Nov;18(11):925-938. doi: 10.1080/14789450.2021.2010549. Epub 2021 Dec 19.
4
Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.基于质谱的蛋白质组学研究抗击 COVID-19：希望与挑战的专家综述。
OMICS. 2022 Jan;26(1):19-34. doi: 10.1089/omi.2021.0182. Epub 2022 Jan 7.
5
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.用恢复期血浆治疗 COVID-19：从过去的冠状病毒爆发中吸取的教训。
Clin Microbiol Infect. 2020 Oct;26(10):1436-1446. doi: 10.1016/j.cmi.2020.08.005. Epub 2020 Aug 11.
6
CoVProt: Toward a Mass Spectrometry Data Portal for COVID-19 Proteomics Research and Development.CoVProt：迈向 COVID-19 蛋白质组学研究与开发的质谱数据门户。
OMICS. 2024 Jan;28(1):24-31. doi: 10.1089/omi.2023.0274. Epub 2024 Jan 9.
7
Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.蛋白质组学和信息学在理解 COVID-19 疾病的阶段和鉴定生物标志物中的应用。
J Proteome Res. 2020 Nov 6;19(11):4219-4232. doi: 10.1021/acs.jproteome.0c00326. Epub 2020 Jul 24.
8
A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.严重急性呼吸综合征（SARS）、中东呼吸综合征（MERS）和 2019 年冠状病毒病（COVID-19）疾病的临床、病毒学、病理学和免疫学特征比较。
Arch Pathol Lab Med. 2021 Oct 1;145(10):1194-1211. doi: 10.5858/arpa.2020-0820-SA.
9
Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.SARS-CoV-2 的蛋白基因组分析：单核苷酸多态性、COVID-19 蛋白质组和宿主反应的临床全景。
J Proteome Res. 2021 Mar 5;20(3):1591-1601. doi: 10.1021/acs.jproteome.0c00808. Epub 2021 Feb 8.
10
Review of Thoracic Imaging Manifestations of COVID-19 and Other Pathologic Coronaviruses.COVID-19 及其他病理性冠状病毒的胸部影像学表现综述。
Radiol Clin North Am. 2022 May;60(3):359-369. doi: 10.1016/j.rcl.2022.01.004. Epub 2022 Jan 11.
引用本文的文献
1
Scalable randomized kernel methods for multiview data integration and prediction with application to Coronavirus disease.用于多视图数据集成和预测的可扩展随机核方法及其在冠状病毒病中的应用
Biostatistics. 2024 Dec 31;26(1). doi: 10.1093/biostatistics/kxaf001.
2
Proteomic lung analysis revealed hyper-activation of neutrophil extracellular trap formation in cases of fatal COVID-19.蛋白质组学肺部分析显示，在致命的新冠病毒疾病（COVID-19）病例中，中性粒细胞胞外诱捕网形成过度激活。
Heliyon. 2024 May 24;10(11):e31878. doi: 10.1016/j.heliyon.2024.e31878. eCollection 2024 Jun 15.
3
Proteomic Analysis of Salivary Extracellular Vesicles from COVID-19 Patients Reveals a Specific Anti-COVID-19 Response Protein Signature.新冠病毒患者唾液外泌体的蛋白质组学分析揭示了一种特定的抗新冠病毒反应蛋白特征。
Int J Mol Sci. 2024 Mar 26;25(7):3704. doi: 10.3390/ijms25073704.
4
Proteomic profiling identifies biomarkers of COVID-19 severity.蛋白质组学分析确定了新冠病毒疾病严重程度的生物标志物。
Heliyon. 2023 Dec 9;10(1):e23320. doi: 10.1016/j.heliyon.2023.e23320. eCollection 2024 Jan 15.
5
Proteomics research of SARS-CoV-2 and COVID-19 disease.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与冠状病毒病（COVID-19）的蛋白质组学研究
Med Rev (2021). 2022 Sep 14;2(4):427-445. doi: 10.1515/mr-2022-0016. eCollection 2022 Aug.
6
Integrative multi-omics approach for identifying molecular signatures and pathways and deriving and validating molecular scores for COVID-19 severity and status.综合多组学方法鉴定 COVID-19 严重程度和状态的分子特征和途径，并构建和验证分子评分。
BMC Genomics. 2023 Jun 12;24(1):319. doi: 10.1186/s12864-023-09410-5.
7
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer's and coronary disease pathways.新型冠状病毒感染与严重程度的血浆蛋白质组学揭示了对阿尔茨海默病和冠心病通路的影响。
iScience. 2023 Apr 21;26(4):106408. doi: 10.1016/j.isci.2023.106408. Epub 2023 Mar 14.
8
Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis.新型冠状病毒肺炎所致脓毒症的血浆酶活性、蛋白质组学和肽组学：一种分析止血功能的新方法
Front Mol Biosci. 2023 Jan 11;9:1051471. doi: 10.3389/fmolb.2022.1051471. eCollection 2022.
9
Towards precision medicine: Omics approach for COVID-19.迈向精准医学：针对2019冠状病毒病的组学方法。
Biosaf Health. 2023 Apr;5(2):78-88. doi: 10.1016/j.bsheal.2023.01.002. Epub 2023 Jan 18.
10
A two-gene marker for the two-tiered innate immune response in COVID-19 patients.COVID-19 患者双层先天免疫反应的双基因标志物。
PLoS One. 2023 Jan 17;18(1):e0280392. doi: 10.1371/journal.pone.0280392. eCollection 2023.
本文引用的文献
1
Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.基于蛋白质组学的新型冠状病毒 2019 引发的 COVID-19 大流行研究进展综述：首年研究成果。
Mol Cell Proteomics. 2021;20:100103. doi: 10.1016/j.mcpro.2021.100103. Epub 2021 Jun 4.
2
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.慢性炎症性疾病患者样本的 SARS-CoV-2 血清学检测中出现假阳性结果。
Front Immunol. 2021 May 3;12:666114. doi: 10.3389/fimmu.2021.666114. eCollection 2021.
3
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.人类A549肺细胞的自身抗原谱揭示了COVID-19自身免疫的病毒和宿主病因分子特征。
J Autoimmun. 2021 Jun;120:102644. doi: 10.1016/j.jaut.2021.102644. Epub 2021 Apr 27.
4
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.多水平蛋白质组学揭示 SARS-CoV-2 和 SARS-CoV 对宿主的干扰。
Nature. 2021 Jun;594(7862):246-252. doi: 10.1038/s41586-021-03493-4. Epub 2021 Apr 12.
5
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol.新冠感染后康复率及长期后果风险如何？一项全球纵向观察研究的协调方案。
BMJ Open. 2021 Mar 10;11(3):e043887. doi: 10.1136/bmjopen-2020-043887.
6
Urine proteome of COVID-19 patients.新冠肺炎患者的尿液蛋白质组
Urine (Amst). 2020;2:1-8. doi: 10.1016/j.urine.2021.02.001. Epub 2021 Mar 5.
7
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.202012/1 感染关注的 SARS-CoV-2 变异株的患者的死亡率风险：匹配队列研究。
BMJ. 2021 Mar 9;372:n579. doi: 10.1136/bmj.n579.
8
SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response.新冠病毒肺炎住院患者的严重急性呼吸综合征冠状病毒2血清转化和病毒清除：病毒载量可预测抗体反应
Open Forum Infect Dis. 2021 Jan 5;8(2):ofab005. doi: 10.1093/ofid/ofab005. eCollection 2021 Feb.
9
Avidity assay to test functionality of anti-SARS-Cov-2 antibodies.用于测试抗SARS-CoV-2抗体功能的亲和力测定。
Vaccine. 2021 Mar 5;39(10):1473-1475. doi: 10.1016/j.vaccine.2021.02.003. Epub 2021 Feb 3.
10
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2.新型冠状病毒肺炎的生物标志物及对抗严重急性呼吸综合征冠状病毒2的技术
Adv Biomark Sci Technol. 2020;2:1-23. doi: 10.1016/j.abst.2020.08.001. Epub 2020 Aug 19.
Zotero 插件